戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 2257735作成日:2026年10月25日

1,2,3,4-Tetrahydro-1,6-dimethyl-2,4-dioxo-3-(4-piperidinyl)quinazoline hydrobromide → 3-[1-(6,7-Dibenzyloxy-4-quinazolinyl)-4-piperidinyl]-1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxoquinazoline

https://huagongshe.com/reaction/2257735

反応式

関与物質

役割名称HCID仕込み量
反応物1,2,3,4-Tetrahydro-1,6-dimethyl-2,4-dioxo-3-(4-piperidinyl)quinazoline hydrobromideHCID 21851222—
反応物HCID 22923433HCID 22923433—
生成物3-[1-(6,7-Dibenzyloxy-4-quinazolinyl)-4-piperidinyl]-1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxoquinazolineHCID 2292348854%

反応手順

The procedure similar to that described in Example 61 was repeated, except that 836.0 mg (2.36 mmol) of 1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxo-3-(4-piperidinyl)-quinazoline hydrobromide (Compound v) obtained in Example 41 was used and 6,7-dibenzyloxy-4-chloroquinazoline was used in place of 4-chloro-6,7-dimethoxyquinazoline. As a result, 786.3 mg (yield: 54%) of Compound 88 was obtained as white crystals.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US05658917
出典データセットuspto-grants-1997_08
ORD IDord-f336b532146b469da03be8aa33306814
出典メモuspto-grants-1997_08